|
InMotion® Robots have been tested by leading medical centers in more than 150, independent controlled clinical trials, including large randomized, double-blind, peer-reviewed clinical studies involving more than 1700 patients.
BIONIK's modular approach to neurorehabilitation is optimizes the use of robotics and is consistent with the latest neuro-scientific research. InMotion® Interactive Therapy serves as an effective adjunct to existing physical and occupational therapy approaches.
In a multi-center, randomized controlled trial involving 127 chronic stroke patients with moderate to severe upper-limb impairment, InMotion therapy demonstrated significant findings:
In a controlled clinical study involving 56 stroke inpatients, the motor skills of the robot-treated group improved significantly more than the control group. Analysis showed that interactive robotic therapy significantly reduced motor impairment of the treated limbs, doubling the impairment reduction.2
BIONIK robotic products have exceptional capacity for patient assessment and real-time interactive response, which sets them apart from other therapy systems.
Global Headquarters
80 Coolidge Hill Road
Watertown, MA 02472
United States
Tel: +1 617.926.4800
support@bioniklabs.com
